Medically reviewed by Katlein Franca, MD Atopic dermatitis may be more challenging for healthcare providers to identify ...

The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050, ...

Medically reviewed by Susan Bard, MD Atopic dermatitis (AD), a common form of eczema, is a chronic (long-term) skin condition ...

Discover how atopic dermatitis affects the Black community differently, from unique symptoms to environmental triggers, and ...

Atopic dermatitis (AD) presents as a long-term, recurring inflammatory disorder of the skin, and its characteristic itching significantly affects patients' daily living standards. The research was ...

Ivarmacitinib Provides Relief in Atopic Dermatitis Study A phase 3 trial shows that ivarmacitinib improves symptoms in adults with moderate to severe atopic dermatitis compared with placebo.

Ivarmacitinib, a selective oral Janus kinase 1 inhibitor, significantly improved signs and symptoms in patients with moderate to severe atopic dermatitis (AD) and showed a favorable safety profile ...

The representation of Black and Asian adults is on the rise in atopic dermatitis clinical trials, according to a study. As ...

What I Wish I Knew Sooner About How People Really View My Eczema What I Wish I Knew About the Victim-Blaming I’d Face by Scratching My Atopic Dermatitis What I Wish I Knew About Atopic ...

In a post-hoc analysis, dupilumab improved symptoms of atopic dermatitis (AD) in young children ages 6 months to 5 years. Youngsters with associated comorbidities such as asthma, allergic rhinitis ...

Knowing that we don't specifically have head-to-head data amongst our biologic therapies in the atopic dermatitis realm, I kind of like to let the clinical data do the talking, to help guide us.